|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
EBOOKCENTRAL_ocn708569317 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
990506s2011 xx a ob 001 0 eng d |
040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d OCLCQ
|d EBLCP
|d OCLCQ
|d OCLCO
|d OCLCQ
|d N$T
|d OCLCF
|d BENTH
|d OCLCQ
|d YDXCP
|d OCLCQ
|d AZK
|d AGLDB
|d ICA
|d MOR
|d PIFAG
|d ZCU
|d MERUC
|d OCLCQ
|d JBG
|d OCLCQ
|d U3W
|d D6H
|d OCLCQ
|d STF
|d WRM
|d VTS
|d COCUF
|d ICG
|d VT2
|d OCLCQ
|d DKC
|d OCLCQ
|d AJS
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
019 |
|
|
|a 819594352
|a 903700715
|a 961634820
|a 962653131
|a 988412687
|a 992114100
|a 1037764319
|a 1038664252
|a 1055333325
|a 1059122608
|a 1081280694
|a 1097116136
|a 1228538735
|
020 |
|
|
|a 9781608051328
|q (electronic bk.)
|
020 |
|
|
|a 1608051323
|q (electronic bk.)
|
029 |
1 |
|
|a DEBBG
|b BV043961047
|
029 |
1 |
|
|a DEBBG
|b BV044162583
|
029 |
1 |
|
|a DEBSZ
|b 48129645X
|
029 |
1 |
|
|a NZ1
|b 15023785
|
029 |
1 |
|
|a AU@
|b 000054714018
|
035 |
|
|
|a (OCoLC)708569317
|z (OCoLC)819594352
|z (OCoLC)903700715
|z (OCoLC)961634820
|z (OCoLC)962653131
|z (OCoLC)988412687
|z (OCoLC)992114100
|z (OCoLC)1037764319
|z (OCoLC)1038664252
|z (OCoLC)1055333325
|z (OCoLC)1059122608
|z (OCoLC)1081280694
|z (OCoLC)1097116136
|z (OCoLC)1228538735
|
050 |
|
4 |
|a RC280.B7
|b A93 2011eb
|
072 |
|
7 |
|a HEA
|x 039110
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 056000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.8
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Anastin and malignant gliomas /
|c editor, Thomas C. Chen ; co-editor, Marc Chamberlain.
|
260 |
|
|
|a [Place of publication not identified] :
|b Bentham e Books,
|c [2011]
|
300 |
|
|
|a 1 online resource (vii, 195 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a data file
|2 rda
|
490 |
1 |
|
|a Controversies in Neuro-Oncology, 1 ;
|v v. 1
|
504 |
|
|
|a Includes bibliographical references and indexes.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a 01 Cover Page.pdf; 02 Title Page; 03 eBooks End User License Agreement-Website; 04 table of contents; 05 Foreword; 06 PREFACE-Avastin; 07 Contributors; 08 Part 1 BASIC SCIENCE AND RATIONALE; 09 Ch-1; 10 Part 2; 11 Ch-2 Desjardins-Avastin-recurrent-chen; 12 Ch-3 kreisl-Avastin_and_Mailgnant_Gliomas_-_Is_there_a_role[1]-chen; 13 Ch-4 GutinRT-_bev_review_FI_PG_9-22[1]-chen; 14 Ch-5 norden_controversies_6-19-09[1]-chen; 15 Part 3; 16 Ch-6 Reardon_chapter_8[1].29; 17 Ch-7 Mehta-radiationControversies_in_Neuro-Avastin-final[1]-chen.
|
505 |
8 |
|
|a 18 Ch-8 Gilbert-Bevacizumab_and_Malignant_Glioma_final_version_9-14-09[1]-Gilbert-chen19 Part 4; 20 Ch-9 Schiff-Avastin toxicityFinal-Bevacizumab_Toxicity_in_Glioblastoma_with_DS_edits_090109-for_review_11[1]-chen corrected; 21 Ch-10 Rogers Chapter_-_Avastin_and_AC_-_Chamberlain_11-2-09__3_[2]-Chen; 22 Part 5; 23 Ch-11 Raizer- AvastinFinal__2_[1]-chen; 24 Part 6; 25 Ch-12 POPE_GBM_Avastin_Imaging[1]-chen; 26 Ch-13 Butowski-radiographic responses 2-chen; 27 Ch-14 Imaging Responses of Bevacizuma; 28 Ch-15 HENSON091509cleanref[1]-chen; 29 Part 7; 30 Ch-16 Aghi-_Avastin_v2[1]-Chen.
|
505 |
8 |
|
|a 31 Ch-17 Vogelbaum-Surgical Implications-Avastin_Final[1]-chen32 Part 8; 33 Ch-18 chamberlain-BevNovelApplications_8_6_09[1]-chen; 34 Ch-19 Levin-Radiation_necrosis-082509-Final[1]-chen; 35 Ch-20 chamberlain-salvage-chen; 36 Part 9; 37 Ch-21 StuppBev_rec_glioma__final[1]-chen; 38 Ch-22 van den Bent-Avastin in Europe-chen; 39 Ch-23 Avastin_Weller_2009-6-30[1]-chen; 40 Ch-24 Wick European pers-chen; 41 Part 10; 42 Ch-25 Sunitinib_ebook_chapter___B_Neyns[1]-chen; 43 Ch-26 nabors-cilengitide-chen; 44 Ch-27 SorafenibChapter_FINAL[2]-chen; 45 Ch-28 Wen-VEGF-trap_8-14-09_FINAL[1]-chen.
|
505 |
8 |
|
|a 46 Ch-29 Batchelor-Gerstner-Dietrich-Cediranib-09-12-09[1]-chen47 Part 11 Conclusion; 48 Ch-30 Gu Development_of_Bevacizumab[1][1]-chen; 49 Author Index -Avastin; 50 Index-final-chen.
|
520 |
|
|
|a Neuro-oncology is an embryonic field of cancer research with a number of clinical trials in progress. However, the prognosis on neuro-oncologic patients has remained poor. Moreover, several small scale phase I/II trials performed have proved to be inconclusive because of the limited number of patients involved. As a result, many controversies exist in neuro-oncology drug development for which a forum does not exist. This ebook presents a detailed account on the use of avastin in treating cancer patients. A discussion on clinical experiences and the controversial debate among researchers of ava.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Gliomas.
|
650 |
|
0 |
|a Bevacizumab.
|
650 |
|
2 |
|a Glioma
|
650 |
|
2 |
|a Bevacizumab
|
650 |
|
6 |
|a Gliome.
|
650 |
|
6 |
|a Bévacizumab.
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x Nervous System (incl. Brain)
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Neurology.
|2 bisacsh
|
650 |
|
7 |
|a Bevacizumab
|2 fast
|
650 |
|
7 |
|a Gliomas
|2 fast
|
700 |
1 |
|
|a Chen, Thomas C.
|
700 |
1 |
|
|a Chamberlain, Marc C.
|
758 |
|
|
|i has work:
|a Anastin and malignant gliomas (Text)
|1 https://id.oclc.org/worldcat/entity/E39PD3H6Td8jd9KbtxMrDR384q
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|a Chen, Thomas C.
|t Controversies in Neuro-Oncology (Avastin and Malignant Gliomas).
|d Sharjah : Bentham Science Publishers, ©2010
|z 9781608053254
|
830 |
|
0 |
|a Controversies in Neuro-Oncology, 1.
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=864213
|z Texto completo
|
938 |
|
|
|a Bentham Science Publisher
|b BENT
|n 9781608051328
|
938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL864213
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10447992
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 500681
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 3628845
|
994 |
|
|
|a 92
|b IZTAP
|